During the past decade, South Florida Research Phase I-IV, INC. conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 5 clinical trials were completed, i.e. on average, 22.7% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 5 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Florida Research Phase I-IV, INC." #1 sponsor was "Nova Biomedical" with 3 trials, followed by "American Regent, Inc." with 2 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Sunovion" with 2 trials sponsored and "Ardelyx" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Florida Research Phase I-IV, INC." #1 collaborator was "Bill and Melinda Gates Foundation" with 1 trials as a collaborator, "CS Lifescience" with 1 trials as a collaborator, "Charisma Medical and Research Center" with 1 trials as a collaborator, "Clinical Trial Mentors" with 1 trials as a collaborator and "DACIMA Software" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "South Florida Research Phase I-IV, INC." are "Alzheimer Disease" (3 trials), "Chronic Kidney Diseases" (2 trials), "Diabetes Mellitus" (2 trials), "Iron Deficiency Anemia" (2 trials) and "Schizophrenia" (2 trials). Many other conditions were trialed in "South Florida Research Phase I-IV, INC." in a lesser frequency.

Most popular intervention types in "South Florida Research Phase I-IV, INC." are "Drug" (19 trials), "Diagnostic Test" (3 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ferric carboxymaltose" (2 trials), "Adalimumab" (1 trials), "Adalimumab placebo" (1 trials) and "Brexpiprazole" (1 trials). Other intervention names were less common.

The vast majority of trials in "South Florida Research Phase I-IV, INC." are 22 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "South Florida Research Phase I-IV, INC.". undefined are not yet recruiting, 10 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in South Florida Research Phase I-IV, INC., 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in South Florida Research Phase I-IV, INC., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".